RT Journal Article SR Electronic T1 Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? JF ERJ Open Research JO erjor FD European Respiratory Society SP 00055-2016 DO 10.1183/23120541.00055-2016 VO 2 IS 2 A1 Stefan Andreas A1 Christer Janson A1 Maarten van den Berge A1 Lies Lahousse YR 2016 UL http://openres.ersjournals.com/content/2/2/00055-2016.abstract AB SUMMIT supports the efficiency and cardiovascular safety of LABA and ICS in COPD patients at cardiovascular risk http://ow.ly/p6Is300ffoc